Ofatumumab treatment for severe refractory anti-NMDAR encephalitis: A case series. Lai R, Wu Z, Wang H, Feng L, et al. J Neuroimmunol 2024;396:578458.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lai R, Wu Z, Wang H, Feng L, et al. Ofatumumab treatment for severe refractory anti-NMDAR encephalitis: A case series. J Neuroimmunol 2024;396:578458.
PMID: 39277986